关注
Levi Collin Nelemans
Levi Collin Nelemans
Msc, UMCG
在 umcg.nl 的电子邮件经过验证
标题
引用次数
引用次数
年份
Drug delivery with polymeric nanocarriers—cellular uptake mechanisms
LC Nelemans, L Gurevich
Materials 13 (2), 366, 2020
1112020
Synthesis, Self-Assembly and In Vitro Cellular Uptake Kinetics of Nanosized Drug Carriers Based on Aggregates of Amphiphilic Oligomers of N-Vinyl-2-pyrrolidone
PP Kulikov, AL Luss, LC Nelemans, MI Shtilman, YO Mezhuev, ...
Materials 14 (20), 5977, 2021
82021
Optimization of protein precipitation for high-loading drug delivery systems for immunotherapeutics
LC Nelemans, M Buzgo, A Simaite
Proceedings 78 (1), 29, 2020
52020
EGFR-selective activation of CD27 co-stimulatory signaling by a bispecific antibody enhances anti-tumor activity of T cells
V Melo, LC Nelemans, M Vlaming, HJ Lourens, VR Wiersma, V Bilemjian, ...
Frontiers in Immunology 14, 1191866, 2023
32023
Pitfalls of accurate protein determination inside PLGA nanoparticles using the micro BCA assay
M Clerici, LC Nelemans, M Buzgo, A Simaite
Proceedings 78 (1), 28, 2020
22020
Antibody desolvation with sodium chloride and acetonitrile generates bioactive protein nanoparticles
LC Nelemans, VA Melo, M Buzgo, E Bremer, A Simaite
Plos one 19 (3), e0300416, 2024
2024
Design of Vaterite Nanoparticles for Controlled Delivery of Active Immunotherapeutic Proteins
LC Nelemans, G Choukrani, N Ustyanovska‐Avtenyuk, VR Wiersma, ...
Particle & Particle Systems Characterization, 2300153, 2024
2024
Signal regulatory protein beta 2 is a novel positive regulator of innate anticancer immunity
N Visser, LC Nelemans, Y He, HJ Lourens, MG Corrales, G Huls, ...
Frontiers in Immunology 14, 1287256, 2023
2023
Supplementary Material EGFR-selective activation of CD27 co-stimulatory signaling by a bispecific antibody enhances anti-tumor activity of T cells
V Melo, LC Nelemans, M Vlaming, HJ Lourens, V Wiersma, V Bilemjian, ...
系统目前无法执行此操作,请稍后再试。
文章 1–9